Journey Medical Corporati... (DERM)
Journey Medical Statistics
Share Statistics
Journey Medical has 23.3M shares outstanding. The number of shares has increased by 4.38% in one year.
| 23.3M |
| 4.38% |
| 0% |
| 18.41% |
| n/a |
| 1,007 |
| 1.05% |
Short Selling Information
The latest short interest is 315.98K, so 1.36% of the outstanding shares have been sold short.
| 315.98K |
| 1.36% |
| 2.66% |
| 3.12 |
Valuation Ratios
The PE ratio is -5.44 and the forward PE ratio is 8.6. Journey Medical's PEG ratio is -0.02.
| -5.44 |
| 8.6 |
| 1.42 |
| 0.6 |
| 3.98 |
| -8.75 |
| -0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Journey Medical.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 1.37, with a Debt / Equity ratio of 1.25.
| 1.37 |
| 0.96 |
| 1.25 |
| -2.99 |
| -2.75 |
| -5.07 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $1,369,121.95 |
| $-357,853.66 |
| 41 |
| 0.7 |
| 1.45 |
Taxes
| 61K |
| -0.42% |
Stock Price Statistics
The stock price has increased by 57.66% in the last 52 weeks. The beta is 0.88, so Journey Medical's price volatility has been higher than the market average.
| 0.88 |
| 57.66% |
| 6.88 |
| 5.58 |
| 53.18 |
| 96,007 |
Income Statement
In the last 12 months, Journey Medical had revenue of 56.13M and earned -14.67M in profits. Earnings per share was -0.72.
| 56.13M |
| 35.26M |
| -13.68M |
| -14.67M |
| -8.4M |
| -11.91M |
| -0.72 |
Balance Sheet
The company has 20.3M in cash and 25.08M in debt, giving a net cash position of -4.78M.
| 20.3M |
| 25.08M |
| -4.78M |
| -87.03M |
| 84.96M |
| 13.76M |
Cash Flow
In the last 12 months, operating cash flow was -9.13M and capital expenditures 0, giving a free cash flow of -9.13M.
| -9.13M |
| n/a |
| -9.13M |
| -0.45 |
Margins
Gross margin is 62.81%, with operating and profit margins of -24.36% and -26.14%.
| 62.81% |
| -24.36% |
| -26.03% |
| -26.14% |
| -14.96% |
| -24.36% |
| -16.26% |
Dividends & Yields
DERM does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for DERM is $10, which is 35% higher than the current price. The consensus rating is "Buy".
| $10 |
| 35% |
| Buy |
| 2 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 0.89 |
| 3 |